Events and Presentations

Investor Presentation
Biostage to Participate at the 2016 World Stem Cell Summit and RegMed Capital Conference
Wednesday, December 7, 2016
2:00pm - 3:00pm EST
Palm Beach County Convention Center
West Palm Beach, Florida

Jim McGorry, CEO of Biostage, will participate presentation and panel discussion at the 2016 World Stem Cell Summit and RegMed Capital Conference on Wednesday, December 7th at 2:00 PM ET, being held at the Palm Beach County Convention Center, West Palm Beach, Florida.

As part of his presentation, Mr. McGorry will discuss the Company's lead product candidate, the Cellspan™ Esophageal Implant, which recently received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA). The Cellspan Esophageal Implant is designed to restore the structure and function of the esophagus subsequent to esophageal damage due to cancer, injury or congenital abnormalities.

About Regenerative Medicine Foundation
The World Stem Cell Summit is a project of the nonprofit Regenerative Medicine Foundation. Since 2003, Regenerative Medicine Foundation and its predecessor Genetics Policy Institute have built the strongest, most comprehensive and trusted global network of Regenerative Medicine stakeholders, uniting the world's leading researchers, medical centers, universities, labs, businesses, funders, policymakers, experts in law, regulation and ethics, medical philanthropies and patient organizations. Our mission is to accelerate regenerative medicine to improve health and deliver cures. We are committed to the ethical advancement of innovative medicine powered by regenerative, restorative, and curative technologies. Learn more at

The World Stem Cell Summit, is the original, translation-focused global meeting of stakeholders, now celebrating its 12th year. The 2016 WSCS is co-sponsored by the The Mayo Clinic Center for Regenerative Medicine and is organized by the Center for the Advancement of Science in Space (CASIS), the sole manager of the International Space Station U.S. National Laboratory; Centre For Commercialization Of Regenerative Medicine (Canada); Diabetes Research Institute Foundation; Kyoto University Institute for Integrated Cell Material Science; Mayo Clinic; NOVA Southeastern University Cell Therapy Institute; The Cure Alliance; University of Miami Miller School of Medicine ISCI (Interdisciplinary Stem Cell Institute); and Wake Forest School of Medicine Institute for Regenerative Medicine. Learn more at

print email rss